We are monitoring the impact of COVID-19 on APAC Diabetes Care Devices Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 83
Share on
Share on

Asia Pacific Diabetes Care Devices Market By Device Type And By Country ( India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecast (2019 - 2024)

Pulished: August, 2019
ID: 83
Pages: 145

The size of the Asia Pacific Diabetes Care Devices Market was estimated at USD 2.75 Billion in 2019. It is expected to reach USD 3.93 billion by 2024, at a CAGR of 7.41% during the forecast period from 2018 to 2023. Diabetes is a group of metabolic disorders, chronic condition which is associated with an abnormally high level of sugar (glucose) in the blood. Southeast Asia currently witnesses 78.3 million people affected with Diabetes which is going to reach 140.2 million by 2040. Western Pacific region witnesses 153.2 million people affected with diabetes and this number are said to reach 214.8 million by 2040. 

The Asia Pacific has the highest diabetes population, with the number increasing at quite an alarming rate. Due to this, there is a massive demand for diabetes care devices which is primarily driving the market here. Also, the increasing healthcare costs are driving the market with increased revenues accumulated by the companies in this region.

But the market growth is constrained here due to low medical literacy rate, which is leading to the fall in sales of devices. 

Regionally, countries like China, India, Japan, Korea, and Australia. China and India are the leading contributors in this region with a significant incidence of companies involved in manufacturing diabetes care devices, due to the highest prevalence of diabetes population in their areas. China has the world’s largest community with close to 1.4 billion people, followed by India, with around 1.2 billion people in 2014. According to the International Diabetes Federation, China had the most significant number of diabetic patients with about 96.2 million diabetic patients followed by India, with around 66.8 million diabetic patients in 2014. It represents a majority of approximately 40-45% of the global diabetic population living in India and China, providing significant opportunities for the global diabetes care devices companies to invest in this region.

Leading companies operating in the APAC Diabetes Care Devices Market profiled in this report are Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Ascensia, Tandem and Terumo.

This research report segmented and sub-segmented into the following categories:

By Type:

  • Glucose Monitoring Devices
    • Self-Blood Glucose Monitoring Devices
        • Glucose Meters
        • Test strips
        • Lancets
        • Hemoglobin A1C Testing Kits    
    • Continuous Glucose Monitoring Devices
  • Insulin Delivery Systems
    • Insulin Syringes
    • Insulin Pens
    • Insulin Pumps
    • Jet Injectors
  • Control Solutions

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 Global Diabetes Care Devices Market, by Type                                                           

                                5.1.1 Glucose Monitoring Devices                                            

                                                5.1.1.1 Self Blood Glucose Monitoring Devices                   

                                                                5.1.1.1.1 Glucose Meters             

                                                                5.1.1.1.2 Test strips        

                                                                5.1.1.1.3 Lancets              

                                                                5.1.1.1.4 Hemoglobin A1c testing Kits     

                                                5.1.1.2 Continous Glucose Monitoring Devices                  

                                5.1.2 Insulin Delivery Systems                                   

                                                5.1.2.1 Insulin Syringes                 

                                                5.1.2.2 Insulin Pens                        

                                                5.1.2.3 Insulin Pumps                    

                                                5.1.2.4 Jet Injectors                        

                                5.1.3 Control Solutions                                  

  1. Geographical Analysis

                6.3 Asia-Pacific                                                 

                                6.1 Introduction                                               

                                6.2 China                                             

                                6.3 India                                              

                                6.4 Japan                                            

                                6.5 South Korea                                               

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 F. Hoffmann-La Roche Ltd                                                    

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Medtronic Inc.                                                          

                8.3 Johnson & Johnson                                                 

                8.4 Abbott Laboratories                                                               

                8.5 Becton, Dickinson and Company                                                       

                8.6 Ascensia Diabetes care                                                          

                8.7 Novo Nordisk A/S                                                    

                8.8 Dexcom, Inc.                                                              

                8.9 Insulet Corporation                                                 

                8.10 Terumo Corporation                                                            

                8.11 Tandem Diabetes Care, Inc                                               

                8.12 Ypsomed AG                                                           

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Diabetes Care Devices Market by Type from 2019-2024 (in $Billion)
  2. Asia-Pacific Glucose Monitoring Devices Market by Region from 2019-2024 (in $Billion)
  3. Asia-Pacific Glucose Monitoring Devices Market by Type from 2019-2024 (in $Billion)
  4. Asia-Pacific Self Monitoring Blood Glucose (SMBG) Market by Region from 2019-2024 (in $Billion)
  5. Asia-Pacific Continuous Glucose Monitoring (CGM) Devices Market by Region from 2019-2024 (in $Billion)
  6. Asia-Pacific Self Monitoring Blood Glucose (SMBG) Market by Type from 2019-2024 (in $Billion)
  7. Asia-Pacific Glucose Meters Market by Region from 2019-2024 (in $Billion)
  8. Asia-Pacific Testing Strips Market by Region from 2019-2024 (in $Billion)
  9. Asia-Pacific Lancets Market by Region from 2019-2024 (in $Billion)
  10. Asia-Pacific Haemoglobin A1C Testing Kits Market by Region from 2019-2024 (in $Billion)
  11. Asia-Pacific Insulin Delivery Devices Market by Region from 2019-2024 (in $Billion)
  12. Asia-Pacific Insulin Delivery Devices Market by Type from 2019-2024 (in $Billion)
  13. Asia-Pacific Insulin Syringes Market by Region from 2019-2024 (in $Billion)
  14. Asia-Pacific Insulin Pumps Market by Region from 2019-2024 (in $Billion)
  15. Asia-Pacific Insulin Pens Market by Region from 2019-2024 (in $Billion)
  16. Asia-Pacific Insulin Jet Injectors Market by Region from 2019-2024 (in $Billion)
  17. Asia-Pacific Control Solutions Market by Region from 2019-2024 (in $Billion)
  18. Asia-Pacific Diabetes Care Devices Market by Region from 2019-2024 (in $Billion)
  19. Asia-Pacific Diabetes Care Devices Market by Region from 2019-2024 (in $Billion)
  20. Asia-Pacific Diabetes Care Devices Market by Type from 2019-2024 (in $Billion)
  21. Asia-Pacific Glucose Monitoring Devices Market by Type from 2019-2024 (in $Billion)
  22. Asia-Pacific Self Monitoring Blood Glucose (SMBG) Market by Type from 2019-2024 (in $Billion)
  23. Asia-Pacific Insulin Delivery Devices Market by Type from 2019-2024 (in $Billion)
  24. China Diabetes Care Devices Market by Type from 2019-2024 (in $Billion)
  25. China Glucose Monitoring Devices Market by Type from 2019-2024 (in $Billion)
  26. China Self Monitoring Blood Glucose (SMBG) Market by Type from 2019-2024 (in $Billion)
  27. China Insulin Delivery Devices Market by Type from 2019-2024 (in $Billion)
  28. India Diabetes Care Devices Market by Type from 2019-2024 (in $Billion)
  29. India Glucose Monitoring Devices Market by Type from 2019-2024 (in $Billion)
  30. India Self Monitoring Blood Glucose (SMBG) Market by Type from 2019-2024 (in $Billion)
  31. India Insulin Delivery Devices Market by Type from 2019-2024 (in $Billion)
  32. Japan Diabetes Care Devices Market by Type from 2019-2024 (in $Billion)
  33. Japan Glucose Monitoring Devices Market by Type from 2019-2024 (in $Billion)
  34. Japan Self Monitoring Blood Glucose (SMBG) Market by Type from 2019-2024 (in $Billion)
  35. Japan Insulin Delivery Devices Market by Type from 2019-2024 (in $Billion)
  36. South Korea Diabetes Care Devices Market by Type from 2019-2024 (in $Billion)
  37. South Korea Glucose Monitoring Devices Market by Type from 2019-2024 (in $Billion)
  38. South Korea Self Monitoring Blood Glucose (SMBG) Market by Type from 2019-2024 (in $Billion)
  39. South Korea Insulin Delivery Devices Market by Type from 2019-2024 (in $Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample